Loading clinical trials...
Loading clinical trials...
Phase III Multicenter Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases
Conditions
Interventions
single-fraction SRS
high-dose hypofractionated SRS
+1 more
Locations
4
United States
Stanford University Medical Center
Stanford, California, United States
John Hopkins Medical Center
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Start Date
December 16, 2014
Primary Completion Date
July 26, 2018
Completion Date
July 26, 2018
Last Updated
February 19, 2019
NCT06244264
NCT04497051
NCT02987153
NCT03363685
NCT01637766
NCT01849510
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions